Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
3,129.00
2,893.00
2,009.00
1,685.00
1,347.00
1,211.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3,129.00
2,893.00
2,009.00
1,685.00
1,347.00
1,211.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
-35.00
0.00
3.00
0.00
-38.00
Raw Materials Consumed
817.00
748.00
379.00
348.00
259.00
276.00
Power & Fuel Cost
12.00
15.00
12.00
5.00
4.00
3.00
Employee Cost
556.00
505.00
403.00
346.00
250.00
229.00
Operating Expenses
76.00
62.00
23.00
13.00
7.00
7.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
208.00
254.00
180.00
158.00
101.00
108.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
150.00
144.00
138.00
102.00
85.00
91.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,009.00
1,876.00
1,334.00
1,148.00
862.00
781.00
Operating Profit (PBDIT) excl Other Income
1,120.00
1,017.00
674.00
536.00
485.00
430.00
Other Income
7.00
18.00
23.00
11.00
26.00
8.00
Operating Profit (PBDIT)
1,127.00
1,035.00
698.00
547.00
511.00
439.00
Interest
192.00
231.00
84.00
26.00
4.00
1.00
Profit before Depriciation and Tax
935.00
804.00
613.00
521.00
506.00
437.00
Depreciation
279.00
315.00
182.00
117.00
64.00
42.00
Profit Before Taxation & Exceptional Items
655.00
488.00
431.00
404.00
442.00
394.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
638.00
488.00
431.00
404.00
442.00
394.00
Provision for Tax
-8.00
114.00
34.00
30.00
36.00
39.00
Profit After Tax
647.00
374.00
397.00
374.00
405.00
355.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
2,792.00
2,540.00
2,155.00
1,873.00
1,550.00
0.00
Profit Available for appropriations
3,412.00
2,892.00
2,547.00
2,255.00
1,956.00
0.00
Appropriations
3,412.00
2,892.00
2,547.00
2,255.00
1,956.00
0.00
Equity Dividend (%)
721.00%
735.00%
0.00%
735.00%
601.00%
550.00%
Earnings Per Share
45.33
25.85
28.82
28.10
29.89
26.16
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 8.15% vs 44.02% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 10.12% vs 50.73% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -16.70% vs 172.75% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 72.83% vs -5.67% in Mar 2025
Compare Profit and Loss Results of ERIS Lifescience
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
3,129.00
1,421.00
1,708.00
120.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,129.00
1,421.00
1,708.00
120.20%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
7.00
-28.00
-400.00%
Raw Materials Consumed
817.00
436.00
381.00
87.39%
Power & Fuel Cost
12.00
37.00
-25.00
-67.57%
Employee Cost
556.00
242.00
314.00
129.75%
Operating Expenses
76.00
125.00
-49.00
-39.20%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
208.00
9.00
199.00
2,211.11%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
150.00
-8.00
158.00
1,975.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,009.00
1,117.00
892.00
79.86%
Operating Profit (PBDIT) excl Other Income
1,120.00
304.00
816.00
268.42%
Other Income
7.00
15.00
-8.00
-53.33%
Operating Profit (PBDIT)
1,127.00
319.00
808.00
253.29%
Interest
192.00
122.00
70.00
57.38%
Profit before Depriciation and Tax
935.00
197.00
738.00
374.62%
Depreciation
279.00
279.00
0.00
0.00%
Profit Before Taxation & Exceptional Items
655.00
-82.00
737.00
898.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
638.00
-91.00
729.00
801.10%
Provision for Tax
-8.00
-18.00
10.00
55.56%
Profit After Tax
647.00
-73.00
720.00
986.30%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2,792.00
-1,843.00
4,635.00
251.49%
Profit Available for appropriations
3,412.00
-1,917.00
5,329.00
277.99%
Appropriations
3,412.00
-1,917.00
5,329.00
277.99%
Equity Dividend (%)
721%
0%
721.00
Earnings Per Share
45.33
-6.44
51.77
803.88%
Profit And Loss - Net Sales
Net Sales 3,129.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.15% vs 44.02% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,120.11 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.12% vs 50.73% in Mar 2025
Profit And Loss - Interest
Interest 192.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.70% vs 172.75% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 647.42 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 72.83% vs -5.67% in Mar 2025
Footer loading
